These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32242058)

  • 21. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
    Liu F; Zhang Q; Liang Y
    J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.
    Pesch AM; Hirsh NH; Michmerhuizen AR; Jungles KM; Wilder-Romans K; Chandler BC; Liu M; Lerner LM; Nino CA; Ward C; Cobain EF; Lawrence TS; Pierce LJ; Rae JM; Speers CW
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34932500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
    Song D; Diao J; Yang Y; Chen Y
    Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1.
    Chung M; Liu C; Yang HW; Köberlin MS; Cappell SD; Meyer T
    Mol Cell; 2019 Nov; 76(4):562-573.e4. PubMed ID: 31543423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site.
    Ravishankar H; Mangani AS; Shankar MB; Joshi M; Devasena T; Parameswaran S; Subramaniam K
    Histochem Cell Biol; 2020 Feb; 153(2):101-109. PubMed ID: 31781967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex ligation-dependent probe amplification versus fluorescent in situ hybridization for screening
    Eid OM; El Zomor H; Mohamed AM; El-Bassyouni HT; Afifi HH; El-Ayadi M; Sadek SH; Hammad SA; Salem SI; Mahrous R; Fadel IM; Refaat K; Afifi MA; Shelil AE; Ziko OAO; Abdel Azeem AA; El-Haddad A
    Ophthalmic Genet; 2022 Dec; 43(6):789-794. PubMed ID: 36098066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
    Tang LH; Contractor T; Clausen R; Klimstra DS; Du YC; Allen PJ; Brennan MF; Levine AJ; Harris CR
    Clin Cancer Res; 2012 Sep; 18(17):4612-20. PubMed ID: 22761470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.
    Beck TN; Georgopoulos R; Shagisultanova EI; Sarcu D; Handorf EA; Dubyk C; Lango MN; Ridge JA; Astsaturov I; Serebriiskii IG; Burtness BA; Mehra R; Golemis EA
    Mol Cancer Ther; 2016 Oct; 15(10):2486-2497. PubMed ID: 27507850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
    Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
    J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALYREF/THOC4 expression and cell growth modulation in retinoblastoma.
    Seigel GM; Onwumere O; Sauane M; Lopez S; Shang E; Habiba H; Redenti S; Grossniklaus HE; Gharbaran R
    Pathol Res Pract; 2024 Aug; 260():155392. PubMed ID: 38880039
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma.
    Sahoo S; Ravi Kumar RK; Nicolay B; Mohite O; Sivaraman K; Khetan V; Rishi P; Ganesan S; Subramanyan K; Raman K; Miles W; Elchuri SV
    FEBS Lett; 2019 Jan; 593(1):23-41. PubMed ID: 30417337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.